Youmanitarian
12 Jun 2021
Biochemical Prostate Cancer Recurrence Post Surgery/RT
15 Vues
TAKE ACTION
Donations would go to support charities for
Comment styliser
Dans
Comment styliser
Physicians provide clarity on how to treat prostate cancer recurrence following definitive therapy based on rapid prostate-specific antigen (PSA) doubling time and comment on what may be the role in Europe of apalutamide (Erleada) and enzalutamide (Xtandi) in the metastatic castration-resistant prostate cancer (M0 CRPC) space, based on the SPARTAN and PROSPER clinical trials.
Montre plus
More ways to take action
Explore ways that you can help bring a solution to this issue.
Create Youms with hashtags Comment styliser
Create a challenge to bring awareness to this issue for people to complete
Create a fundraiser to support a charity that tackle this issue
Volunteer at charitable organization that support this cause
Create a movement page dedicated to this cause to bring awareness.
Start a uCharity for this cause and invite people to join it to support this cause
